Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction
- 1 July 1990
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 417 (4), 299-304
- https://doi.org/10.1007/bf01605780
Abstract
The presence of decay-accelerating factor (DAF) was clearly demonstrated on the surface of normal cardiomyocytes. In patients who had died of myocardial infarction (MI) cardiomyocytes displayed different appearances: outside the ischaemically damaged region the myocytes showed no significant variations in DAF expression when compared with controls without MI. Within myocardial zones damaged by ischaemia, however, apparently normal myocytes showed large gaps in surface staining of DAF or formed clusters which were entirely devoid of reactivity with anti-DAF antibodies. The number of DAF-deficient myocytes increased with the extent of necrosis and also with the number of days between onset of MI and death. Even though injury to myocytes is to a large extent related to anoxia and to the presence of free oxygen radicals, the complement system also appears to be involved; DAF may have protective functions against complement-mediated injury. We speculate that phospholipase may be involved in the removal of DAF from the cardiomyocyte surface.Keywords
This publication has 46 references indexed in Scilit:
- Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.Journal of Clinical Investigation, 1990
- Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Journal of Clinical Investigation, 1989
- Decay-accelerating Factor in Human Skin Is Associated with Elastic FibersJournal of Investigative Dermatology, 1988
- Identification of an acid-lipase in human serum which is capable of solubilizing glycophosphatidylinositol-anchored proteinsBiochemical and Biophysical Research Communications, 1988
- Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium.Journal of Clinical Investigation, 1987
- Decay‐accelerating Factor (DAF): A Review of its Function and StructureActa Medica Scandinavica, 1987
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- A Glycophospholipid Tail at the Carboxyl Terminus of the Thy-1 Glycoprotein of Neurons and ThymocytesScience, 1985
- Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.The Journal of Experimental Medicine, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981